Literature DB >> 24682653

Canonical BMP-Smad signalling promotes neurite growth in rat midbrain dopaminergic neurons.

Shane V Hegarty1, Louise M Collins, Aisling M Gavin, Sarah L Roche, Sean L Wyatt, Aideen M Sullivan, Gerard W O'Keeffe.   

Abstract

Ventral midbrain (VM) dopaminergic (DA) neurons project to the dorsal striatum via the nigrostriatal pathway to regulate voluntary movements, and their loss leads to the motor dysfunction seen in Parkinson's disease (PD). Despite recent progress in the understanding of VM DA neurogenesis, the factors regulating nigrostriatal pathway development remain largely unknown. The bone morphogenetic protein (BMP) family regulates neurite growth in the developing nervous system and may contribute to nigrostriatal pathway development. Two related members of this family, BMP2 and growth differentiation factor (GDF)5, have neurotrophic effects, including promotion of neurite growth, on cultured VM DA neurons. However, the molecular mechanisms regulating their effects on DA neurons are unknown. By characterising the temporal expression profiles of endogenous BMP receptors (BMPRs) in the developing and adult rat VM and striatum, this study identified BMP2 and GDF5 as potential regulators of nigrostriatal pathway development. Furthermore, through the use of noggin, dorsomorphin and BMPR/Smad plasmids, this study demonstrated that GDF5- and BMP2-induced neurite outgrowth from cultured VM DA neurons is dependent on BMP type I receptor activation of the Smad 1/5/8 signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682653     DOI: 10.1007/s12017-014-8299-5

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  109 in total

1.  Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos.

Authors:  W C Smith; R M Harland
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

Review 2.  Morphogen signaling at the vertebrate growth cone: a few cases or a general strategy?

Authors:  Paola Bovolenta
Journal:  J Neurobiol       Date:  2005-09-15

Review 3.  Morphogens and the control of cell proliferation and patterning in the spinal cord.

Authors:  Fausto Ulloa; James Briscoe
Journal:  Cell Cycle       Date:  2007-08-01       Impact factor: 4.534

Review 4.  Progress in Parkinson's disease-where do we stand?

Authors:  André Toulouse; Aideen M Sullivan
Journal:  Prog Neurobiol       Date:  2008-06-05       Impact factor: 11.685

5.  The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry.

Authors:  Colleen Manitt; Andrea Mimee; Conrad Eng; Matthew Pokinko; Thomas Stroh; Helen M Cooper; Bryan Kolb; Cecilia Flores
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

6.  Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals.

Authors:  James P Dugan; Andrea Stratton; Hilary P Riley; W Todd Farmer; Grant S Mastick
Journal:  Mol Cell Neurosci       Date:  2010-11-27       Impact factor: 4.314

7.  Distribution of the catecholaminergic neurons in the central nervous system of human embryos and fetuses.

Authors:  C Verney
Journal:  Microsc Res Tech       Date:  1999-07-01       Impact factor: 2.769

8.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

9.  Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration.

Authors:  A M Sullivan; J Opacka-Juffry; J Pohl; S B Blunt
Journal:  Brain Res       Date:  1999-02-06       Impact factor: 3.252

10.  Ephrin-A5 regulates the formation of the ascending midbrain dopaminergic pathways.

Authors:  Margaret A Cooper; Kazuto Kobayashi; Renping Zhou
Journal:  Dev Neurobiol       Date:  2009-01       Impact factor: 3.964

View more
  23 in total

1.  Echinacoside Protects Against MPP(+)-Induced Neuronal Apoptosis via ROS/ATF3/CHOP Pathway Regulation.

Authors:  Qing Zhao; Xiaoyan Yang; Dingfang Cai; Ling Ye; Yuqing Hou; Lijun Zhang; Jiwei Cheng; Yuan Shen; Kaizhe Wang; Yu Bai
Journal:  Neurosci Bull       Date:  2016-07-18       Impact factor: 5.203

2.  Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.

Authors:  Louise M Collins; Giorgia Dal Bo; Mariangela Calcagno; Jimena Monzón-Sandoval; Aideen M Sullivan; Humberto Gutierrez; Michele Morari; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

3.  Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult.

Authors:  Louise M Collins; Luc J Adriaanse; Surabhi D Theratile; Shane V Hegarty; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2014-07-29       Impact factor: 5.590

Review 4.  Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons.

Authors:  Shane V Hegarty; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2014-02-07       Impact factor: 5.590

5.  BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells.

Authors:  Vukasin M Jovanovic; Ahmad Salti; Hadas Tilleman; Ksenija Zega; Marin M Jukic; Hongyan Zou; Roland H Friedel; Nilima Prakash; Sandra Blaess; Frank Edenhofer; Claude Brodski
Journal:  J Neurosci       Date:  2018-01-10       Impact factor: 6.167

6.  The effect of extrinsic Wnt/β-catenin signaling in Muller glia on retinal ganglion cell neurite growth.

Authors:  Ganeswara Rao Musada; Galina Dvoriantchikova; Ciara Myer; Dmitry Ivanov; Sanjoy K Bhattacharya; Abigail S Hackam
Journal:  Dev Neurobiol       Date:  2020-04-17       Impact factor: 3.964

7.  A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.

Authors:  Shane V Hegarty; Eimear O'Leary; Franziska Solger; Joanna Stanicka; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neurotox Res       Date:  2016-06-02       Impact factor: 3.911

8.  Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring.

Authors:  Eileen A Curran; Gerard W O'Keeffe; Ann Marie Looney; Gerard Moloney; Shane V Hegarty; Deirdre M Murray; Ali S Khashan; Louise C Kenny
Journal:  Mol Neurobiol       Date:  2017-10-03       Impact factor: 5.590

9.  Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration.

Authors:  Susan R Goulding; Martin Lévesque; Aideen M Sullivan; Louise M Collins; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-03-12       Impact factor: 5.590

Review 10.  Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.

Authors:  Shane V Hegarty; Gerard W O'Keeffe; Aideen M Sullivan
Journal:  Neural Regen Res       Date:  2014-10-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.